Abstract
Methods:
We performed an initial analysis in the first data release sample (LifeLines I) from the LifeLines cohort study (n=7,976 subjects). Job-specific exposure was estimated with the ALOHA+job exposure matrix. Effects of SNP-by-occupational exposure interaction on respiratory symptoms were tested using a logistic regression model adjusted for gender, age, and current smoking. SNPs with a SNP-by-occupational exposure interaction p-value < 10 -4 were replicated in the second LifeLines data release sample (LifeLines II; n=5,260) and the Vlagtwedde-Vlaardingen cohort study (n=1,529) using meta-analysis. Additionally, we assessed whether replicated SNPs influenced gene expression by analyzing if they were cis-acting expression (mRNA) quantitative trait loci (eQTL) in lung tissue.
Results:
A total of 24 out of 599 SNPs-by-occupational exposure interactions were significantly replicated and 11 of these 24 interactions were in the same direction in all cohorts. Several of these loci were plausible candidates for respiratory symptoms, given their important function in the lungs, such as TMPRSS9, TOX3, and ARHGAP18. Three of 11 replicated SNPs were cis-acting eQTL associated with gene expression of FCER1A, CHN1 and TIMM13 in lung tissue.
Conclusions
This genome-wide interaction study in the context of occupational exposures in relation to cough, dyspnea, and phlegm identified several susceptibility genes. Further research should investigate the function of the identified genes in relation to occupational exposures.
Introduction
Occupational exposures have been associated with low levels of lung function, high risk for respiratory symptoms and COPD (1) (2) (3) (4) . Respiratory symptoms in adults are related to impaired quality of life regardless of asthma and COPD (5) . Previous candidate gene approaches have shown that genetic variants may affect the level of lung function (6) and the risk for respiratory symptoms (7) . For example polymorphisms in ADAM33 were associated with decline in lung function and genetic polymorphisms in TLR4 were associated with work-related respiratory symptoms (8, 9) . Clearly, these candidate gene studies were driven by hypotheses relying on known biological pathways. Contrary to that, a genome-wide association study (GWAS) can identify genetic loci across the entire genome in a hypothesis free manner. However, most single GWASes do not replicate consistently, which might be caused by environmental factors that trigger the development of symptoms only in subjects with a specific genotype. More recently, hypothesis free genome-wide interaction studies (GWIS) were performed to identify genetic loci that affect the susceptibility to known harmful exposures (10) (11) (12) . We have recently performed a GWAS on respiratory symptoms, and found no significant associations between genetic loci and respiratory symptoms including cough, dyspnea and phlegm (paper submitted). This strengthens the suggestion that genetic determinants may play an important role only in combination with specific environmental exposures such as occupational exposures. Therefore, it is necessary to investigate genetic susceptibility to environmental exposure in relation to respiratory symptoms using a GWIS.
We have previously shown that genetic susceptibility is associated with lung function level (FEV 1 ) in the context of occupational exposure to biological dust, mineral dust and gases and fumes, and that several of these novel identified susceptibility loci were cis-acting eQTLs in lung tissue (10) . Whether such gene-by-occupational exposure interactions exist in relation to respiratory symptoms is largely unknown.
The aim of the current GWIS was to identify susceptibility loci for several types of occupational exposures in relation to the respiratory symptoms cough, dyspnea, and phlegm in a general population cohort. We used two independent cohorts to confirm our findings. This may shed light on the genetic susceptibility to specific exposures leading to respiratory symptoms.
Methods

Identification cohort
Genotyped individuals from the first data release of the LifeLines cohort study (LifeLines I) with full data on all covariates were included (n = 7,976). The LifeLines cohort study is a general population based cohort that started in 2006, including subjects from the three Northern provinces of the Netherlands (10, 13) . Participants completed a standardized questionnaire, and provided written informed consent. The study protocol was approved by the local medical ethics committee.
Replication cohorts
To verify our initial findings, we included 5,260 subjects from the second data release of the LifeLines cohort study (LifeLines II) and 1,529 subjects with full data on genotypes and covariates on the last survey in 1989/1990 from the Vlagtwedde-Vlaardingen cohort, a prospective general population based cohort (8, 14) . Both the identification and replication cohorts included only Caucasian individuals of Dutch descent.
Genotyping and quality control
Blood samples of all subjects included in the identification and replication cohorts were genotyped using IlluminaCytoSNP-12 arrays. Samples with call rates < 95% were excluded. SNPs that fulfilled the quality control criteria were included: genotype call-rate ≥ 95% (on average a call-rate of > 99% is achieved), minor allele frequency (MAF) ≥ 1%, and Hardy-Weinberg equilibrium (HWE) cut-off p-value ≥ 10 -4 . A total of 227,981 genotyped SNPs were included in the identification analysis. Non-Caucasian samples and first-degree relatives were excluded.
Respiratory symptoms
Cough, dyspnea, and phlegm were defined by a standardized questionnaire from the European Community Respiratory Health Survey (ECRHS) in LifeLines I and LifeLines II (15) (16) . Cough was defined as at least one positive answer to the questions: "do you usually cough first thing in the morning in the winter?" or "do you usually cough during the day, or at night, in winter?". Dyspnea was defined as a positive answer to the question: "are you troubled by shortness of breath when hurrying on level ground or walking up a slight hill or stairs at normal pace?". Phlegm was defined as at least one positive answer to the questions: "do you usually bring up any phlegm from your chest first thing in the morning in winter?" or "do you usually bring up any phlegm from your chest during the day, or at night, in winter?".
Occupational exposure
Self-reported job title and descriptions were coded according to the International Standard Classification of Occupations version 1988 (ISCO-88) (10, 17) . These four-digit codes were used to estimate job-specific exposure to vapors, gas, dust or fumes (VGDF), biological dust, mineral dust, gas and fumes, pesticides, herbicides, insecticides, aromatic solvents, chlorinated solvents, other solvents, and metals using the ALOHA+ Job Exposure Matrix (JEM) (1, 18) . The ALOHA+ JEM classifies subjects based on the ISCO-88 job codes into no, low and high exposure. In this study, "no exposure" was recoded to "0", and both "low exposure" and "high exposure" were recoded to "1".
Statistical analysis
The data are presented as median (min-max) for continuous variables and as frequencies (percentages) for categorical variables. SNPs were tested in an additive genetic model. Effects of gene-environment interactions on the respiratory symptoms cough, dyspnea, and phlegm were tested by including the SNP, the occupational exposure and the SNP-by-occupational exposure interaction term in a logistic regression model adjusted for sex, age, and current smoking (no/yes) in the software package PLINK (version 1.07) (19) . SNPs with a SNP-by-occupational exposure interaction p-value < 10 -4
were taken forward for replication in the two independent cohorts. The interaction estimates of the two replication cohorts were meta-analyzed using PLINK. Replication was achieved when the p-value of the meta-analysis was < 0.05 and the interaction effect was in the same direction as in the identification cohort. SNP annotation was performed using HaploReg version 4.1 (Broad Institute) (20) .
Gene expression analysis
We assessed whether the replicated SNPs were cis-acting expression (mRNA) quantitative trait loci (eQTLs) in a lung tissue database established by the lung eQTL consortium (21) . Lung tissue was collected from patients who underwent lung resectional surgery at three participating sites; University of Groningen, Laval University, and University of British Columbia (21) . DNA samples were genotyped with Illumina Human1M-Duo BeadChip arrays, and gene expression profiles were obtained using a custom Affymetrix array (GEO accession number GPL10379 and GSE23546). A total of 1,087 subjects with no missing data were included in the analysis. The association between the SNPs and gene expression levels (log transformed) were tested in each cohort separately by linear regression analysis adjusted for disease status, age, gender, smoking status and a cohort specific number of principal components, followed by a meta-analysis of the results of the 3 cohorts. A cis-eQTL was defined as a SNP that was significantly associated with expression levels of a gene within a 1 Mb (in both directions) distance of that SNP, with a p-value below the Bonferroni corrected threshold (p = 0.05/number of probe sets within the 2 Mb window) in the meta-analysis.
Results
Characteristics of the study populations and the prevalence of exposures and respiratory symptoms are shown in Table 1 . The prevalence of smoking, occupational exposures and respiratory symptoms were higher in the Vlagtwedde-Vlaardingen cohort compared to LifeLines I and LifeLines II. The genomic inflation factor for the identification sample suggests little population stratification for SNP-by-occupational exposures interaction models such as SNP-by-biological dust exposure on cough, SNP-by-mineral dust exposure on dyspnea and SNP-by-aromatic solvent exposure on phlegm (λ = 0.99, 1.01, 1.02, respectively, online supplement Figure S1 ).
SNP by exposures interactions Cough
We identified 205 SNPs that interacted with the investigated occupational exposures on cough in the identification cohort (p-values for interaction < 10 -4 ) (table 2). In total 8 SNP-by-exposure interactions (3.9%) had a p <0.05 in the meta-analysis of the replication cohorts, of which 2 interactions were in the same direction as in the identification cohort (Figure1, Table 2 and Table 3 ). 
Dyspnea
We identified 220 SNPs that interacted with the investigated occupational exposures on dyspnea in the identification cohort (p-values for interaction < 10 -4 ) ( Table 2 ). In the meta-analysis of the replication cohorts, interactions with 12 SNPs (5.5%) had a p <0.05 of which 6 interactions were in the same direction as in the identification cohort (Figure2, Table 2 and Table 4 ). 
Phlegm
We identified 174 SNPs that interacted with the investigated occupational exposures on phlegm in the identification cohort (p-values for interaction < 10 -4 ) ( Table 2) . A total 4 SNP-by-occupational exposure interactions (2.3%) showed a significant association (p <0.05) in the meta-analysis of the replication cohorts, of which 3 interactions were in the same direction as in the identification cohort (Figure3, Table 2 and Table 5 ). (20)), 2 SNPs (rs6851156 and rs4380004) could not be assessed for their association with gene expression levels in lung tissue. Three SNPs showed cis-eQTL associations with p-values below the Bonferroni corrected threshold (Table S1 ). SNP rs11265204 that significantly interacted with exposure to biological dust on cough was associated with expression of FCER1A (p = 1.99 × 10 
Discussion
To our knowledge this is the first GWIS focusing on the effects of SNPs-by-occupational exposure interactions on respiratory symptoms. We identified and replicated two SNPs that were associated with cough in subjects with occupational exposure to biological dust and metals, respectively. Six SNPs were identified and replicated in SNP-by-occupational exposure interaction analysis on dyspnea in subjects with exposure to VGDF, mineral dust, gases and fumes, and insecticides. Three SNPs were associated with phlegm in subjects with exposure to biological dust, aromatic solvents, and other solvents, respectively. Several identified SNPs were located in genes that have important functions in the lung and may play a role in pathways associated with respiratory symptoms (i.e. TMPRSS9, TOX3, ARHGAP18, and FCER1A) (Table S2 ). In addition, three SNPs were associated with gene expression levels in the lung which indicate their possible functional relevance.
Findings of the identification cohort were replicated in two independent cohorts. The occupational exposure definition was the same in all cohorts, and estimated by the ALOHA+ JEM that is specifically designed for population-based studies (22) , and less likely to be affected by recall bias or differential misclassification when compared to self-report (23) . We investigated a broad range of occupational exposures, being VGDF, biological dust, mineral dust, gases and fumes, pesticides, herbicides, insecticides, aromatic solvents, chlorinated solvents, other solvents, and metals, related to the respiratory symptoms cough, dyspnea and phlegm.
The minor allele of rs7252511, a SNP in TMPRSS9, was associated with a higher risk of dyspnea in subjects exposed to mineral dust. In lung tissue this SNP rs7252511 showed a cis-eQTL association with higher expression of the gene TIMM13, which partially overlaps in antisense orientation with TMPRSS9, and may have a similar function as TMPRSS9 in the lung (24) . TMPRSS9, known as polyserase-1, is a type II transmembrane serine protease and has a unique structure including three tandem serine protease domains (i.e., serase-1, -2, and -3) (25) . Serase-1B is known to interact with glycosaminoglycans (GAGs), which maintain lung structure and function modulate the inflammatory response, influence tissue repair and remodeling, and protect against injury in various respiratory diseases (25) (26) (27) . Serase-1B and urokinase-type plasminogen activator (uPA) receptor can efficiently activate uPA, which is involved in epithelial repair and airway remodeling, and links with asthma susceptibility, bronchial hyperresponsiveness, and decline in lung function (28) (29) (30) . Occupational exposure to mineral dust is a well-known risk factor for reduced lung growth and COPD (31-34) of which dyspnea is one of the main symptoms. Our results demonstrate that subjects carrying the minor allele of this SNP in TMPRSS9 are especially vulnerable to these harmful effects of mineral dust exposure Another interesting finding is the association between rs3095611, a SNP in TOX3, and a higher risk of phlegm in subjects exposed to aromatic solvents. TOX3 is a neuronal survival factor that regulates calcium dependent transcription in neurons (35) . TOX3 contains a nuclear localization signal and a high-mobility group (HMG) box domain, indicating that it may be involved in bending and unwinding of DNA and alteration of chromatin structure (36) (37) (38) . In addition, TOX3 is mediating inflammatory responses in the lung (35) (36) (37) (38) (39) . Our results indicate there is interaction between TOX3 and exposure to aromatic solvents regarding the risk of phlegm. When aromatic solvents enter the body by inhalation, they can cause respiratory inflammatory, upper respiratory tract damage, and, interestingly, chronic bronchitis, with phlegm as an important symptom (40) (41) (42) (43) . Our results suggest that subjects carrying the minor alleles of this SNP in TOX3 are more susceptible to the respiratory effects of exposure to aromatic solvents.
Exposure to other solvents (i.e. non-aromatic solvents such as formaldehyde and dimethylformamide) is a risk factor for phlegm in subjects carrying the minor allele of rs7758025 in the ARHGAP18 gene. ARHGAP18 regulates the integrity and morphogenesis of epithelial cells (44, 45) . The epithelial cells in lungs provide structural integrity, moisten and protect the airways, are a physical barrier against environmental exposures, and prevent infection and tissue injury by action of the mucociliary escalator (46, 47) . Genetic variation in the ARHGAP18 gene may thus result in an impaired or altered epithelial barrier function, which might lead to increased phlegm production upon exposure to non-aromatic solvents.
The cis-eQTL analysis showed three additional associations that are of interest. The first was an association between the intergenic SNP rs11265204 and a lower expression of FCER1A. In our analysis, the interaction between rs11265204 and biological dust was significantly associated with a lower risk to cough. Polymorphisms in FCER1A are associated with IgE levels and allergic sensitization (48) (49) (50) , and therefore, speculations are that FCER1A is associated with asthma via IgE (51, 52) . Given that cough is a symptom associated with asthma and allergy (53), our results indicating a lower expression of FCER1A and a lower risk of exposure-associated coughing in subjects carrying the minor alleles of rs11265204 thus seems plausible. The second cis-eQTL is rs11682476 (proxy-SNP for rs7588395) which is associated with lower expression of CHN1. According to our analysis, the interaction between rs7588395 and metal exposure was significantly associated with cough. CHN1 encodes α2-chimaerin which is a non-protein kinase C phorbol ester receptor with Rac-GTPase-activating protein activity and cysteine-rich domain (CRD). Ahmed et al demonstrated that cysteine-rich proteins indicate the presence of metal-binding domains, where metals, usually zinc, play a structural role in maintaining the function of these domains, such as dimer formation and DNA-binding (54) . In the current study, we found that subjects with the major allele of rs7588395 and exposure to metals had increased prevalence of cough. An important paralog of this gene is ARHGAP18 which belongs, like CHN1, to a family of Rho GTPase-activating proteins. Therefore, CHN1 may have a similar function in the lung as ARHGAP18. The third cis-eQTL is rs7252511 associated with higher expression of gene TIMM13 with some overlap in sequence with TMPRSS9, and may play a similar important role as TMPRSS9 does in the lung (24) .
Since GWISes are an explorative approach, we used a more liberal p-value threshold (p < 10 -4 ) for identification of SNPs in the identification cohort to keep the risk low of not detecting a true association between SNP-by-occupational exposure interactions and respiratory symptoms. When we assessed these interactions in the independent replication cohorts, the total number of significant gene-by-exposure interactions in the replication meta-analysis is less than expected by chance (i.e. 24 out of 599 (approximately 4.1%) had a p-value < 0.05). However, given the putative function of the identified genes and the association with gene expression levels we think the associations may be true findings. Further research is necessary to confirm this.
In conclusion, this is the first GWIS on the risk of respiratory symptoms cough, dyspnea and phlegm, which investigated interactions between SNPs and several types of occupational exposures. We identified some plausible candidate genes that may be involved in biological pathways leading to respiratory symptoms, i.e. FCER1A, CHN1, TMPRSS9, TOX3, and ARHGAP18. The next step should be to determine if the identified genes are true susceptibility loci for respiratory symptoms. This study may eventually contribute to the understanding of pathways underlying the development of respiratory symptoms. Figure S1 . QQ-plots for the marginal association of the SNP-by-biological dust exposure on cough (A), SNP-by-mineral dust exposure on dyspnea (B) and SNP-by-aromatic solvent exposure on phlegm (C) in the identification samples, adjusted for sex, age and current smoking. Rs11682476 and rs7588395 were in strong LD (r 2 = 0.99); rs4353434 and rs4380004
were in strong LD (r 2 = 1.00); and rs1420546 and rs3095611 were in strong LD (r 2 = 0.93).
